Clinical Trial

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine.

Study acronym: FAST-EM-2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter, prospective, double-blind, multi-arm, randomized controlled trial that investigates whether middle meningeal artery embolization is superior to current standard pharmacotherapy for migraine. The main objectives of the study are to explore whether middle meningeal artery embolization can reduce migraine patients' dependence on migraine medications and to assess the safety of middle meningeal artery embolization with coils.
Trial Details
NCT Number NCT07633067
Lead Sponsor The Affiliated Hospital Of Guizhou Medical University
Collaborators: Sichuan Action Medical Technology Co., Ltd., Juhui Medical Technology (Shenzhen) Co., Ltd., Beijing Xinke Medical Technology Co., Ltd.
Conditions Migraine
Enrollment 150 participants
Start Date 2026-06-15
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-08